ELCC 2026: AI-Assisted PD-L1 Assessment in Lung Cancer

Fred R. Hirsch, MD, PhD, Executive Director of the Center for Thoracic Oncology at Mount Sinai, USA, presented at ELCC 2026 findings from the IHC Blueprint Project, in which an AI platform was applied to PD-L1 assessment in lung cancer. In 80 tumor specimens previously reviewed by 24 expert pathologists, AI performed at least as well as manual scoring and outperformed one assay.